You are here:
Pharmaceutical & Chemicals — Broad Healthcare Exposure
Last Updated:February 23, 2026
About This Investor
JP-B-124
Priority theme: They are looking for a wide range of pharmaceutical – related (medical, chemical) jobs. The primary M&A purpose is Expand existing businesses overseas. Geographic preference: Priority country: Indonesia Possible countries: Asia. Minority Ownership Majority Ownership 100% Acquisition. Budget range is $3.27M – $65.4M, subject to diligence and investment terms. Japan – based, they…
Pharmaceuticals & Chemicals
Asia, Indonesia
Overseas Expansion
$3.27M - $65.4M
Minority / Majority / 100%
Request Full Investor Profile
Similar Investors
JP-B-117
Geographic and deal conditions are important for this mandate: Priority
Wholesale & Distribution
Australia, Canada, Malaysia, New Zealand, Singapore, USA, Vietnam
Overseas Expansion
$6.54M - $32.7M
Majority / 100% | Profit ≥ USD 2M | Compliance required
JP-B-59
Headquartered in Japan, this investor is building pipeline coverage and
Construction / Industrial Parks
ASEAN, Vietnam
Strategic Expansion
$13.1M - $52.3M
Minority / Majority
JP-B-292
With roots in Japan, they are seeking targets that match
Hazardous Logistics
Asia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam
Strategic Synergy
$3.27M - $32.7M
Minority / Majority / 100%